Wednesday, April 13th, 2016 adds Global Antibody Conjugates Drugs Market 2016-2020 latest research report, the analysts forecast the global antibody conjugates drugs market to grow at a CAGR of 41.58% during the period 2016-2020.

According to the antibody conjugates drugs market report, products in the late pipeline stages will likely be launched during the forecast period. Some of these products include glembatumumab vedotin by Seattle Genetics, trastuzumab by Synthon Biopharmaceuticals, and SGN-35 by Takeda Pharmaceuticals. Some molecules are in the Phase I/II, preclinical, and discovery stages. ADCETRIS is currently under clinical trials for additional indications such as frontline mature T-cell lymphomas, B-cell lymphomas, and CD30-expressing conditions.

The global antibody conjugates drugs market an analyst said strategic alliances, in terms of collaboration and licensing, helps co-develop and commercialize drugs in different regions. Co-development agreements between companies enable the use of technical expertise from both companies. It also allows the use of regulatory and development experience gained by one company for the support of the pipeline candidates of the other company. Such agreements ensure the in-flow of adequate funds for both the companies and help reduce the liability costs of individual companies in case of failures, attracting more venture investments.

Inquire for more information @

Segmentation by Mechanism of Action and Analysis of the Antibody Conjugates Drugs market – IgG1 antibodies and HER2 antibodies

IgG is an antibody composed of four peptide chains and helps control the infection of tissues by binding to the pathogen such as virus, bacteria, and fungi. Moreover, these antibodies play an important role in intracellular antibody-mediated proteolysis and antibody dependent cell mediated toxicity. IgG1 find extensive applications in immunotherapy and drug development, thereby propelling the growth prospects of the antibody conjugates drugs market. 

Geographical Segmentation and Analysis of the Antibody Conjugates Drugs Market – APAC, EMEA and America

In this industry report, the analysts have estimated that the Americas will dominate the global antibody conjugates drugs market until the end of 2020. This segment held the largest market share of more than 50% during 2015. The US was the largest revenue contributor in this region due to increasing incidences and prevalence of cancers. Order a copy of Global Antibody Conjugates Drugs Market 2016-2020 report @

The global antibody conjugates drugs market is highly competitive due to the presence of only three major providers in the market. The entry of new vendors is likely to intensify the competition, both in terms of innovation and technology in the forecast period. The competitive environment is expected to increase in due to the product extensions, new products, and new applications of the products and services provided.  

 Key players in the antibody conjugate drugs market: F. Hoffmann-La Roche AG, Seattle Genetics Inc., and Takeda Pharmaceutical Company.

Other Prominent Vendors in the market are: AbbVie, AbGenomics, ADC Therapeutics, Agensys, ALMAC Group, Ambrx, Astellas Pharma, AstraZeneca, Bayer HealthCare, CARBOGEN AMCIS, Celldex Therapeutics, Daiichi Sankyo, Endo Pharmaceuticals, Esperance Pharmaceuticals, Formation Biologics, Genmab, GlaxoSmithKline, Immunogen, Kairos Therapeutics, MedImmune, Mersana Therapeutics, Novartis, Oxford Biotherapeutics, Pfizer, Stemcentrx, Synthon Biopharmaceuticals, and Zymeworks.

 Further, the report states that the high developmental costs of antibody conjugates negatively impact the growth of the antibody conjugates drugs market.

File Library

Contact Profile

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect With Us on:  



Twitter: https: //

G+ / Google Plus:



Ritesh Tiwari
P: + 1 888 391 5441


Antibody Conjugates Drugs Market, Antibody Conjugates Drugs Industry, Global Antibody Conjugates Drugs Market, Antibody Conjugates Drugs Market 2016, Market Research Reports




More Formats

View QR Code